Stay updated on Ascending Dose Study of ZFN Therapeutic SB-913 in MPS II Clinical Trial
Sign up to get notified when there's something new on the Ascending Dose Study of ZFN Therapeutic SB-913 in MPS II Clinical Trial page.

Latest updates to the Ascending Dose Study of ZFN Therapeutic SB-913 in MPS II Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedPublication note now states that PubMed entries are automatically filled and may not pertain to the study, and the revision tag has been updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check28 days agoChange DetectedThe site-wide funding-status notice near the top of the page has been removed. The study details and related information remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check42 days agoChange DetectedThe Study Details page shows only minor visual/layout changes with no updates to core content such as eligibility criteria, endpoints, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check71 days agoChange Detected- Added a prominent notice about potential outages due to lapse in government funding and updated operating status guidance. - Updated version from v3.1.0 to v3.2.0.SummaryDifference4%

- Check78 days agoChange DetectedExpanded core topics to include Sudden Infant Death Syndrome and related terms; removed the older version label (v3.0.2) in favor of v3.1.0.SummaryDifference1%

- Check93 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2; the 'Back to Top' link was removed. No substantial changes to core content, pricing, stock, or time-sensitive information.SummaryDifference0.2%

Stay in the know with updates to Ascending Dose Study of ZFN Therapeutic SB-913 in MPS II Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ascending Dose Study of ZFN Therapeutic SB-913 in MPS II Clinical Trial page.